Jérôme Estaquier
Chercheur universitaire
Axe Maladies infectieuses et immunitaires
Dernières nouvelles
Voir tout
Publications
Voir tout-
article Gimenez S, Hamrouni E, André S, Picard M, Soundaramourty C, Lozano C, Vincent T, Tran TA, Kundura L, Estaquier J, Corbeau P
Monocytic reactive oxygen species-induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine
J Allergy Clin Immunol 155 (5), 2025.
-
article Clain JA, Picard M, Rabezanahary H, André S, Boutrais S, Goma Matsetse E, Dewatines J, Dueymes Q, Thiboutot E, Racine G, Soundaramourty C, Mammano F, Corbeau P, Zghidi-Abouzid O, Estaquier J
Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus Macaques
Infect Dis Rep 17 (1), 2025.
-
article Kundura L, Cezar R, Ballongue E, André S, Michel M, Mettling C, Lozano C, Vincent T, Muller L, Lefrant JY, Roger C, Claret PG, Duvnjak S, Loubet P, Sotto A, Tran TA, Estaquier J, Corbeau P
Low Percentage of Perforin-Expressing NK Cells during Severe SARS-CoV-2 Infection: Consumption Rather than Primary Deficiency
J Immunol 212 (7), 2024.
Projets
- Therapeutic approach to preserve Tfh cells and improve B cell immunity in simian immunodeficiency virus infected rhesus macaques, du 2021-04-01 au 2026-03-31
- National Primate Center for Pandemic Preparedness (NPCPP), du 2024-03-01 au 2028-03-31
- Pre-clinical tools and services for deciphering the repertoires of B and T cells elicited by the immune response in non-human primates (NHP), du 2025-04-08 au 2027-06-30
- Canadian HIV Cure Enterprise 3.0: Targeting tissue HIV reservoirs, du 2025-01-01 au 2029-12-31
- Metabolism of transcriptionally active cells associated with viral reactivation in lymphoid tissues. An approach to cure AIDS, du 2025-02-01 au 2026-01-31
- Deciphering the genomic and immunological factors contributing to asymptomatic Leishmania infantum infections in humans, du 2025-04-01 au 2026-03-31
- Chaire de recherche du Canada en physiopathologie de la mort cellulaire dans les interactions hôtes-pathogènes, du 2018-04-01 au 2025-03-31
- Canadian HIV Cure Enterprise 2.0: Targeting the interplay between myeloid cells and C04+ T-cells for HIV cure, du 2019-04-01 au 2025-03-31
- Manufacturing of antigens and adjuvants for development of vaccines (MAAV), du 2021-07-01 au 2024-03-31
- Prevention of the immunopathology induced by SARS-CoV-2, du 2021-06-01 au 2025-03-31
- Contribution VRRCI - 32e Congrès canadien de recherche sur le VIH/sida (ACRV 2023), du 2023-03-01 au 2024-04-30